Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 0 | 6 | 352 | 516 |
| Cost of Goods | N/A | N/A | N/A | 173 | 236 |
| Gross Profit | N/A | N/A | 6 | 179 | 280 |
| Operating Expenses | 11,502 | 10,844 | 9,025 | 4,978 | 2,307 |
| Operating Income | -11,502 | -10,844 | -9,019 | -4,626 | -1,792 |
| Other Income | -224 | -2,462 | -777 | -751 | -984 |
| Pre-tax Income | -11,726 | -13,306 | -9,796 | -5,377 | -2,775 |
| Net Income Continuous | -11,726 | -13,306 | -9,796 | -5,377 | -2,775 |
| Net Income | $-11,726 | $-13,306 | $-9,796 | $-5,377 | $-2,775 |
| EPS Basic Total Ops | -22,027.97 | -81,818.18 | -75,874.13 | -68,181.82 | -134,265.70 |
| EPS Basic Continuous Ops | -21,362.16 | -62,032.47 | -76,032.55 | -68,192.12 | -134,219.70 |
| EPS Diluted Total Ops | -22,027.97 | -81,818.18 | -75,874.13 | -68,181.82 | -134,265.70 |
| EPS Diluted Continuous Ops | -21,362.16 | -62,032.47 | -76,032.55 | -68,192.12 | -134,219.70 |
| EPS Diluted Before Non-Recurring Items | -22,027.97 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,104 | $-8,124 | $-8,222 | $-3,853 | $-827 |